FDA Issues Warning Letter to Peptide Partners Over Unapproved Injectable Drugs
On August 24, 2026, the U.S. Food and Drug Administration sent a warning letter to Peptide Partners LLC, a Sarasota, Flo...
Read story →Tag: Fda
View all →
Merck Secures First Oral PCSK9 Inhibitor, Boosts Q1 2026 Earnings and Expands Oncology Pipeline
Merck’s latest triumph—an FDA nod for its first oral PCSK9 inhibitor—comes on the heels of a stronger‑than‑exp...
Read story →
Indivior Prepares for Q1 2026 Earnings Amid Legal Scrutiny and Product Pipeline Developments
Indivior Pharmaceuticals Inc. (NASDAQ: INDV) will report its first‑quarter 2026 financial results on Thursday, April 3...
Read story →
Corvention Secures FDA 510(k) Clearance for KardiaPSI Balloon Catheter, Plans Controlled Market Rollout
In a quiet Flagstaff office, a breakthrough that could change aortic‑valve treatment finally cleared the FDA’s most ...
Read story →